BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

385 related articles for article (PubMed ID: 20055167)

  • 1. Antibody-drug conjugates as targeted cancer therapeutics.
    Sun Y; Yu F; Sun BW
    Yao Xue Xue Bao; 2009 Sep; 44(9):943-52. PubMed ID: 20055167
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Targeted cancer therapy: conferring specificity to cytotoxic drugs.
    Chari RV
    Acc Chem Res; 2008 Jan; 41(1):98-107. PubMed ID: 17705444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Antibody conjugate therapeutics: challenges and potential.
    Teicher BA; Chari RV
    Clin Cancer Res; 2011 Oct; 17(20):6389-97. PubMed ID: 22003066
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Guided molecular missiles for tumor-targeting chemotherapy--case studies using the second-generation taxoids as warheads.
    Ojima I
    Acc Chem Res; 2008 Jan; 41(1):108-19. PubMed ID: 17663526
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antibody-targeted drugs and drug resistance--challenges and solutions.
    Shefet-Carasso L; Benhar I
    Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Toward an effective targeted chemotherapy for multiple myeloma.
    Polson AG; Sliwkowski MX
    Clin Cancer Res; 2009 Jun; 15(12):3906-7. PubMed ID: 19509145
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Internalization, Trafficking, Intracellular Processing and Actions of Antibody-Drug Conjugates.
    Xu S
    Pharm Res; 2015 Nov; 32(11):3577-83. PubMed ID: 26108878
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antibody-drug conjugates and their application in the treatment of hematological malignancies].
    Lin L; Ding Q; Tang Q; Zhang ZZ; Dai Z; Zhan JB
    Yao Xue Xue Bao; 2012 Oct; 47(10):1287-96. PubMed ID: 23289140
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibody-cytotoxic agent conjugates for cancer therapy.
    Chen J; Jaracz S; Zhao X; Chen S; Ojima I
    Expert Opin Drug Deliv; 2005 Sep; 2(5):873-90. PubMed ID: 16296784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Challenges in the development and manufacturing of antibody-drug conjugates.
    Ducry L
    Methods Mol Biol; 2012; 899():489-97. PubMed ID: 22735971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Current methods for the synthesis of homogeneous antibody-drug conjugates.
    Sochaj AM; Świderska KW; Otlewski J
    Biotechnol Adv; 2015 Nov; 33(6 Pt 1):775-84. PubMed ID: 25981886
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibody drug conjugates - Trojan horses in the war on cancer.
    Iyer U; Kadambi VJ
    J Pharmacol Toxicol Methods; 2011; 64(3):207-12. PubMed ID: 21843648
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Monoclonal antibody-based therapies in cancer: advances and challenges.
    Sapra P; Shor B
    Pharmacol Ther; 2013 Jun; 138(3):452-69. PubMed ID: 23507041
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody conjugates and therapeutic strategies.
    McCarron PA; Olwill SA; Marouf WM; Buick RJ; Walker B; Scott CJ
    Mol Interv; 2005 Dec; 5(6):368-80. PubMed ID: 16394252
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibody-drug conjugates in cancer therapy.
    Sievers EL; Senter PD
    Annu Rev Med; 2013; 64():15-29. PubMed ID: 23043493
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhanced activity of monomethylauristatin F through monoclonal antibody delivery: effects of linker technology on efficacy and toxicity.
    Doronina SO; Mendelsohn BA; Bovee TD; Cerveny CG; Alley SC; Meyer DL; Oflazoglu E; Toki BE; Sanderson RJ; Zabinski RF; Wahl AF; Senter PD
    Bioconjug Chem; 2006; 17(1):114-24. PubMed ID: 16417259
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody targeted drugs as cancer therapeutics.
    Schrama D; Reisfeld RA; Becker JC
    Nat Rev Drug Discov; 2006 Feb; 5(2):147-59. PubMed ID: 16424916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Targeted immunotherapy for colorectal cancer: monoclonal antibodies and immunotoxins.
    Shapira S; Lisiansky V; Arber N; Kraus S
    Expert Opin Investig Drugs; 2010 Apr; 19 Suppl 1():S67-77. PubMed ID: 20374033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug-monoclonal antibody conjugates for cancer therapy: potentials and limitations.
    Pimm MV
    Crit Rev Ther Drug Carrier Syst; 1988; 5(3):189-227. PubMed ID: 3060267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antibody-drug conjugates for the treatment of B-cell non-Hodgkin's lymphoma and leukemia.
    Chu YW; Polson A
    Future Oncol; 2013 Mar; 9(3):355-68. PubMed ID: 23469971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.